| Alternative Name: | Fibroblast growth factor 6, Heparin secretory-transforming protein 2, HST-2, HSTF-2, HBGF-6 |
| |
| MW: | ~18.9 kDa |
| |
| Source: | Produced in E. coli. Contains 169 amino acids. |
| |
| UniProt ID: | P10767 |
| |
| Formulation: | Lyophilized from a sterile (0.2 micron) filtered solution containing 10 mM sodium phosphate and 50 mM sodium chloride, pH 7.5. |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Endotoxin Content: | ≤1 EU/µg protein (LAL test) |
| |
| Biological Activity: | 3T3 proliferation with 1 µg heparin; ED50 ≤ 1 ng/mL (≥ 1.0 x 105 units/mg). |
| |
| Reconstitution: | Reconstitute in sterile water at 0.1 mg/mL. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -80°C. For long term storage, it is recommended to dilute to working aliquots in a 0.1% BSA solution. |
| |
| Scientific Background: | Fibroblast growth factor 6 (FGF-6) is an important factor driving muscle differentiation and regeneration. FGF-6 is a heparin-binding growth factor that is expressed in epithelial and mesenchymal lineages. FGF-6 binds and signals through the FGF receptors FGFR1, FGFR2, and FGFR4. FGF-6 functions as a mitogen for vascular endothelial cells and fibroblasts. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
